GSL Synthetase Inhibitor
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GSL Synthetase Inhibitor, covering 2025-07-29 to 2026-02-11. Get the full timeline:
Most recent: Clinical Trial Update: GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC. [Phase 2]